Metformin protects against intestinal ischemia-reperfusion injury and cell pyroptosis via TXNIP-NLRP3-GSDMD pathway
2020 · Redox Biology · 314 citations
https://doi.org/10.1016/j.redox.2020.101534
K
Kai Qu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
159
Papers
4.9K
Citations
37
h-index
87
i10-index
Kai Qu is an academic researcher from Xidian University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Cancer-related molecular mechanisms research & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 37, co-authored 136 publications.
ORCID: 0000-0002-1138-3727Papers by this author
worksGenomic <i>ERBB2</i> / <i>ERBB3</i> mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis
2018 · Gut · 199 citations
https://doi.org/10.1136/gutjnl-2018-316039
Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1
2015 · Acta Pharmacologica Sinica · 104 citations
https://doi.org/10.1038/aps.2014.122
LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis
2017 · EBioMedicine · 88 citations
https://doi.org/10.1016/j.ebiom.2017.12.013
CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NFκB pathway in hepatocellular carcinoma
2020 · Cell Death and Disease · 56 citations
https://doi.org/10.1038/s41419-020-2528-7
Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis
2023 · Journal of Nanobiotechnology · 34 citations
https://doi.org/10.1186/s12951-023-02040-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat